Mark Marsh

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 10

Top Venues

Viruses

PLoS pathogens

Life science alliance

BMC biology

University College London

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University College London Jan 01 2006

United Kingdom

Director :: MRC Laboratory for Molecular Cell Biology

Publications

Scott P Lawrence, Samra E Elser, Workineh Torben, Robert V Blair, Bapi Pahar, Pyone P Aye, Faith Schiro, Dawn Szeltner, Lara A Doyle-Meyers, Beth S Haggarty, Andrea P O Jordan, Josephine Romano, George J Leslie, Xavier Alvarez, David H O'Connor, Roger W Wiseman, Christine M Fennessey, Yuan Li, Michael Piatak, Jeffrey D Lifson, Celia C LaBranche, Andrew A Lackner, Brandon F Keele, Nicholas J Maness, Mark Marsh, James A Hoxie
A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection. PLoS pathogens 18 (6) (2022)
Emma Touizer, Christian Sieben, Ricardo Henriques, Mark Marsh, Romain F Laine
Application of Super-Resolution and Advanced Quantitative Microscopy to the Spatio-Temporal Analysis of Influenza Virus Replication. Viruses 13 (2) (2021)
Yue Yuan, Caron A Jacobs, Isabel Llorente Garcia, Pedro Matos Pereira, Scott P Lawrence, Romain F Laine, Mark Marsh, Ricardo Henriques
Single-Molecule Super-Resolution Imaging of T-Cell Plasma Membrane CD4 Redistribution upon HIV-1 Binding. Viruses 13 (1) (2021)
Camilla T O Benfield, Farrell MacKenzie, Markus Ritzefeld, Michela Mazzon, Stuart Weston, Edward William Tate, Boon Han Teo, Sarah E Smith, Paul Kellam, Edward C Holmes, Mark Marsh
Correction: Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domain. Life science alliance 3 (6) (2020)
Joanna Bednarska, Annegret Pelchen-Matthews, Pavel Novak, Jemima J Burden, Peter A Summers, Marina K Kuimova, Yuri Korchev, Mark Marsh, Andrew Shevchuk
Rapid formation of human immunodeficiency virus-like particles. Proceedings of the National Academy of Sciences of the United States of America 117 (35) (2020)
Michela Mazzon, Mark Marsh
Targeting viral entry as a strategy for broad-spectrum antivirals. F1000Research 8 (2019)
Camilla T O Benfield, Farrell MacKenzie, Markus Ritzefeld, Michela Mazzon, Stuart Weston, Edward William Tate, Boon Han Teo, Sarah E Smith, Paul Kellam, Edward C Holmes, Mark Marsh
Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domain. Life science alliance 3 (1) (2019)
Michela Mazzon, Ana Maria Ortega-Prieto, Douglas Imrie, Christin Luft, Lena Hess, Stephanie Czieso, Joe Grove, Jessica Katy Skelton, Laura Farleigh, Joachim J Bugert, Edward Wright, Nigel J Temperton, Richard Angell, Sally Oxenford, Michael Jacobs, Robin Ketteler, Marcus Dorner, Mark Marsh
Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry. Viruses 11 (2) (2019)
Michela Mazzon, Cecilia Castro, Bastian Thaa, Lifeng Liu, Margit Mutso, Xiang Liu, Suresh Mahalingam, Julian Leether Griffin, Mark Marsh, Gerald M McInerney
Alphavirus-induced hyperactivation of PI3K/AKT directs pro-viral metabolic changes. PLoS pathogens 14 (1) (2018)
David O Nkwe, Annegret Pelchen-Matthews, Jemima J Burden, Lucy M Collinson, Mark Marsh
The intracellular plasma membrane-connected compartment in the assembly of HIV-1 in human macrophages. BMC biology 14 (2016)

Mark Marsh.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mark Marsh